arrow
S

Susanne M. Arnold

University of Kentucky
H指数:43
被引数:7,074

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Genes associated with genetic and rare lung diseases and the risk of lung cancer

与遗传性和罕见性肺部疾病以及肺癌风险的基因

2026-04-010
OAAI
A phase 1 study of berzosertib (M6620, VX-970) in combination with cisplatin and radiation in patients with locally advanced head and neck squamous cell carcinoma (ETCTN 9950)

I期研究:berzosertib(M6620,VX-970)联合顺铂和放疗治疗局部晚期头颈鳞状细胞癌患者(ETCTN 9950)

Cancer
IF5.1
2026-03-150
OAAI
Multicellular immune ecotypes within solid tumors predict real-world therapeutic benefits with immune checkpoint inhibitors

实体瘤内的多细胞免疫生态型可预测免疫检查点抑制剂的实际治疗效果

2025-11-130
OAAI
Genome-wide association study for lung cancer in 6531 African Americans reveals new susceptibility loci

6531名非裔美国人肺癌的全基因组关联研究揭示了新的易感基因位点

2025-05-080
PRE
Differential Infiltration of Key Immune T-Cell Populations Across Malignancies Varying by Immunogenic Potential and the Likelihood of Response to Immunotherapy

关键免疫T细胞群在恶性肿瘤中的差异浸润,其免疫原性潜力和对免疫疗法的反应可能性各不相同

CELLS
IF5.2
2024-12-030
OAAI
Results from KEYMAKER-U01 substudy 3: a phase 2 umbrella study of pembrolizumab plus investigational agents in patients with non-small-cell lung cancer (NSCLC) previously treated with anti-PD-(L)1 therapy
2024-04-050
PRE
Analysis of clonal heterogeneity within paired primary and metastatic tumor samples of patients with solid tumors and implications for neoantigen-based personalized cancer vaccines
2024-03-220
PRE
Differential infiltration of key immune cell populations across malignancies varying by immunogenic potential and likelihood of response to immunotherapy
2024-03-220
PRE
Lung Cancer in Ever- and Never-Smokers: Findings from Multi-Population GWAS Studies

永远和从不吸烟者的肺癌: 多人群gis研究的发现

2024-01-053
OA
CYP2A6 Activity and Cigarette Consumption Interact in Smoking-Related Lung Cancer Susceptibility

CYP2A6活性与吸烟相关肺癌易感性的相互作用

2023-12-201
PRE
Identification of genetically predicted DNA methylation markers associated with non-small cell lung cancer risk among 34,964 cases and 448,579 controls

在34,964病例和448,579对照中鉴定与非小细胞肺癌风险相关的遗传预测的DNA甲基化标记

CANCER
IF5.1
2023-12-060
OAAI
Candidate pathway analysis of surfactant proteins identifies CTSH and SFTA2 that influences lung cancer risk
2023-07-202
PRE